Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marçal Pastor-Anglada

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Pharmacogenomics|October 4, 2013
Transporter pharmacogenetics: do we need function? Do we need motion?Marçal Pastor-Anglada
Pharmaceutics|September 23, 2022
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and PharmacodynamicsMercè Brunet, Marçal Pastor-Anglada
Frontiers in Pharmacology|July 3, 2018
Who Is Who in Adenosine TransportMarçal Pastor-Anglada, Sandra Pérez-Torras
Nucleosides, Nucleotides & Nucleic Acids|December 13, 2025
Building together a "<i>trencadís"</i> of nucleotide metabolismLars Petter Jordheim, Marçal Pastor-Anglada
Pharmacogenomics|May 28, 2010
Drug transporter pharmacogenetics in nucleoside-based therapiesEkaitz Errasti-Murugarren, Marçal Pastor-Anglada
Medicinal Research Reviews|February 3, 2011
Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognitionPedro Cano-Soldado, Marçal Pastor-Anglada
The Journal of Biological Chemistry|February 23, 2010
All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanismPaula Fernández-Calotti, Marçal Pastor-Anglada
Frontiers in Pharmacology|February 26, 2015
Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targetsMarçal Pastor-Anglada, Sandra Pérez-Torras
Frontiers in Pharmacology|June 22, 2018
Emerging Roles of Nucleoside TransportersMarçal Pastor-Anglada, Sandra Pérez-Torras
Biochemical and Biophysical Research Communications|August 15, 2002
Cell-cycle-dependent regulation of CNT1, a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent nucleoside-derived anticancer drugsRaquel Valdés, F Javier Casado, Marçal Pastor-Anglada
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Pharmacogenomics|October 4, 2013
Transporter pharmacogenetics: do we need function? Do we need motion?Marçal Pastor-Anglada
Pharmaceutics|September 23, 2022
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and PharmacodynamicsMercè Brunet, Marçal Pastor-Anglada
Frontiers in Pharmacology|July 3, 2018
Who Is Who in Adenosine TransportMarçal Pastor-Anglada, Sandra Pérez-Torras
Nucleosides, Nucleotides & Nucleic Acids|December 13, 2025
Building together a "<i>trencadís"</i> of nucleotide metabolismLars Petter Jordheim, Marçal Pastor-Anglada
Pharmacogenomics|May 28, 2010
Drug transporter pharmacogenetics in nucleoside-based therapiesEkaitz Errasti-Murugarren, Marçal Pastor-Anglada
Medicinal Research Reviews|February 3, 2011
Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognitionPedro Cano-Soldado, Marçal Pastor-Anglada
The Journal of Biological Chemistry|February 23, 2010
All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanismPaula Fernández-Calotti, Marçal Pastor-Anglada
Frontiers in Pharmacology|February 26, 2015
Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targetsMarçal Pastor-Anglada, Sandra Pérez-Torras
Frontiers in Pharmacology|June 22, 2018
Emerging Roles of Nucleoside TransportersMarçal Pastor-Anglada, Sandra Pérez-Torras
Biochemical and Biophysical Research Communications|August 15, 2002
Cell-cycle-dependent regulation of CNT1, a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent nucleoside-derived anticancer drugsRaquel Valdés, F Javier Casado, Marçal Pastor-Anglada
Pageof 10